Tag Archives: Australia

Patenting “Natural Products” Down-Under Post-Myriad

Although the Australian High Court held that claims to naturally occurring DNA (e.g., BRCA1 nucleic acid) were not patent eligible because they were not a “manner of manufacture,” since the encoded information therein was not “made” by human action, in … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , , , , | 1 Comment

Australia – High Court Decision on Methods of Medical Treatment

This is a guest post from Bill Bennett of Pizzeys in Australia. It covers Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50 (4 December 2013). (A copy of the full decision is available at the end of … Continue reading

Posted in Australian Practice | Tagged , , , , , , , , , | Leave a comment

Major Changes to IP Law in Australia Enacted

This guest post by Tom Gumley, PhD, a partner in the well-known Freehills Patent and Trademark firm provides a lengthy guide to the changes wrought by Australia’s new patent law, that was enacted on April 15, 2012. The law brings … Continue reading

Posted in Int'l Practice and Policy | Tagged , , , , , , , , | Leave a comment

A Scheme For Maximizing The Benefits Available Under The Patent Prosecution Highway (PPH)

This post is from Mark Horsburgh of Fisher Adams Kelly in Australia. Summary File in Australia first; Request expedited examination (report issues within 3 months); Address objections and obtain acceptance; File in USA and request entry to PPH (faster and … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , , , , , , | Leave a comment